Sarbanes, Baltimore Congressional Delegation Announce Nearly $775,000 for Drug Addiction Research at Johns Hopkins University

FOR IMMEDIATE RELEASE
July 23, 2020
CONTACT: Daniel Jacobs
(202) 225-4016

WASHINGTON, D.C. – Congressman John Sarbanes (D-Md.) today joined the Baltimore Congressional Delegation in announcing $774,845 in federal funding for Johns Hopkins University to support critical research on drug use and addiction.

The funding, which comes through the National Institute on Drug Abuse (NIDA), will explore innovative intervention treatment for opioid use disorders. Specifically, the funding will enable researchers to evaluate the effectiveness of new medical technology known as the Bridge Device, a neuromodulator that helps patients with opioid withdrawal symptoms.

“The opioid epidemic – exacerbated by the COVID-19 pandemic –continues to upend communities and destroy lives across Maryland and our nation,” the lawmakers said. “This funding will provide crucial support in evaluating a potential new tool for expanding substance use disorder treatment and recovery. We will keep fighting to increase access to recovery resources and save the lives of those who suffer from this terrible disease.”

The Johns Hopkins Drug Discovery Program was founded in 2009. Scientists in this program study toxicology, drug metabolism, biochemistry and the impacts of drugs on the human neurological system. See here for more information.

The NIDA has advanced addiction science for decades, studying the consequences of opioids and addiction to further inform and protect the public. See here for more information about NIDA.

###